1.75
-0.01(-0.57%)
Currency In USD
| Previous Close | 1.76 |
| Open | 1.76 |
| Day High | 1.87 |
| Day Low | 1.7 |
| 52-Week High | 316.8 |
| 52-Week Low | 1.46 |
| Volume | 86,208 |
| Average Volume | 1.25M |
| Market Cap | 2.61M |
| PE | -0.02 |
| EPS | -114.19 |
| Moving Average 50 Days | 3.2 |
| Moving Average 200 Days | 6.57 |
| Change | -0.01 |
If you invested $1000 in Bluejay Diagnostics, Inc. (BJDX) since IPO date, it would be worth $0.04 as of May 10, 2025 at a share price of $1.75. Whereas If you bought $1000 worth of Bluejay Diagnostics, Inc. (BJDX) shares 3 years ago, it would be worth $0.2 as of May 10, 2025 at a share price of $1.75.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting
GlobeNewswire Inc.
Apr 15, 2025 11:00 AM GMT
New clinical data from the SYMON-I study to evaluate IL-6 in sepsis patients to be presented.ACTON, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), today announced acceptance of an abstract related to the Symphon
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
GlobeNewswire Inc.
Apr 07, 2025 9:21 PM GMT
ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care
Bluejay Diagnostics Announces Reverse Stock Split
GlobeNewswire Inc.
Nov 13, 2024 10:10 PM GMT
ACTON, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care s